Susquehanna International Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $324K | Buy |
|
|||||
|
2025
Q1 | $140K | Buy |
|
|||||
|
2024
Q4 | $177K | Buy |
|
|||||
|
2024
Q3 | $199K | Buy |
|
|||||
|
2024
Q2 | $175K | Sell |
|
|||||
|
2024
Q1 | $685K | Sell |
|
|||||
|
2023
Q4 | $570K | Sell |
|
|||||
|
2023
Q3 | $922K | Sell |
|
|||||
|
2023
Q2 | $2.31M | Sell |
|
|||||
|
2023
Q1 | $4.97M | Buy |
|
|||||
|
2022
Q4 | $369K | Sell |
|
|||||
|
2022
Q3 | $2.83M | Buy |
|
|||||
|
2022
Q2 | $2.88M | Buy |
|
|||||
|
2022
Q1 | $2.13M | Sell |
|
|||||
|
2021
Q4 | $6.21M | Buy |
|
|||||
|
2021
Q3 | $5.11M | Buy |
|
|||||
|
2021
Q2 | $2.87M | Sell |
|
|||||
|
2021
Q1 | $3.48M | Sell |
|
|||||
|
2020
Q4 | $6.44M | Sell |
|
|||||
|
2020
Q3 | $5.33M | Buy |
|
|||||
|
2020
Q2 | $3.82M | Buy |
|
|||||
|
2020
Q1 | $784K | Sell |
|
|||||
|
2019
Q4 | $1.87M | Buy |
|
|||||
|
2019
Q3 | $1.16M | Buy |
|
|||||
|
2019
Q2 | $1.09M | Buy |
|
|||||
|
2019
Q1 | – | Hold |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $260K | Sell |
|
|||||
|
2018
Q1 | $278K | Sell |
|
|||||
|
2017
Q4 | $300K | Buy |
|